Literature DB >> 24917965

Do we need to eradicate Helicobacter pylori in patients with GORD?

Tatsuhiro Masaoka1, Hidekazu Suzuki1.   

Abstract

Eradication of Helicobacter pylori should not be avoided because of complicated reflux symptoms. Previously, although H. pylori eradication in patients with GORD was considered to induce unfavourable effects that worsen reflux symptoms, recent reports indicates that it can have favourable consequences by reducing symptoms and therefore improving quality of life, especially in GORD patients without severe corpus atrophy or severe hiatal herniation.

Entities:  

Keywords:  GORD; Helicobacter pylori; heartburn; reflux oesophagitis; symptom

Year:  2013        PMID: 24917965      PMCID: PMC4040786          DOI: 10.1177/2050640613497713

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  20 in total

1.  Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis.

Authors:  J Labenz; A L Blum; E Bayerdörffer; A Meining; M Stolte; G Börsch
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Authors:  Peter Malfertheiner; Francis Megraud; Colm A O'Morain; John Atherton; Anthony T R Axon; Franco Bazzoli; Gian Franco Gensini; Javier P Gisbert; David Y Graham; Theodore Rokkas; Emad M El-Omar; Ernst J Kuipers
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

3.  Helicobacter pylori and Gastric Mucosa-associated Lymphoid Tissue (MALT) Lymphoma: Updated Review of Clinical Outcomes and the Molecular Pathogenesis.

Authors:  Hidekazu Suzuki; Yoshimasa Saito; Toshifumi Hibi
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

Review 4.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

5.  Augmented levels of gastric mucosal leucocyte activation by infection with cagA gene-positive Helicobacter pylori.

Authors:  H Suzuki; M Suzuki; M Mori; T Kitahora; H Yokoyama; S Miura; T Hibi; H Ishii
Journal:  J Gastroenterol Hepatol       Date:  1998-03       Impact factor: 4.029

6.  Effects of a Helicobacter pylori eradication regimen on anti-platelet autoantibody response in infected and uninfected patients with idiopathic thrombocytopenic purpura.

Authors:  Atsuko Asahi; Masataka Kuwana; Hidekazu Suzuki; Toshifumi Hibi; Yutaka Kawakami; Yasuo Ikeda
Journal:  Haematologica       Date:  2006-09-07       Impact factor: 9.941

7.  High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis.

Authors:  H Hamada; K Haruma; M Mihara; T Kamada; M Yoshihara; K Sumii; G Kajiyama; M Kawanishi
Journal:  Aliment Pharmacol Ther       Date:  2000-06       Impact factor: 8.171

Review 8.  Helicobacter pylori: present status and future prospects in Japan.

Authors:  Hidekazu Suzuki; Toshifumi Hibi; Barry James Marshall
Journal:  J Gastroenterol       Date:  2007-02-16       Impact factor: 7.527

Review 9.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

10.  Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy.

Authors:  Kenro Hirata; Hidekazu Suzuki; Juntaro Matsuzaki; Tatsuhiro Masaoka; Yoshimasa Saito; Toshihiro Nishizawa; Eisuke Iwasaki; Seiichiro Fukuhara; Sawako Okada; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2013-03-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.